Parallax Volatility Advisers, L.P. Kura Oncology, Inc. Transaction History

Parallax Volatility Advisers, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$11.23 - $16.9 $4,323 - $6,506	385 New	385 $4,000
Q4 2018 Feb 14, 2019	SELL	$10.6 - $17.49 $53 - $87	-5 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$16.65 - $21.85 $66,516 - $87,290	-3,995 Reduced 99.88%	5 $0
Q1 2018 May 15, 2018	SELL	$14.5 - $23.4 $42,630 - $68,796	-2,940 Reduced 42.36%	4,000 $75,000
Q4 2017 Feb 14, 2018	SELL	$13.5 - $16.65 $41,310 - $50,948	-3,060 Reduced 30.6%	6,940 $106,000
Q3 2017 Nov 14, 2017	BUY	$6.05 - $14.95 $60,500 - $149,500	10,000	10,000 $150,000

185

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $598M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.